Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2013

Open Access 01-12-2013 | Research article

S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease

Authors: Carmen R Sunico, Tomohiro Nakamura, Edward Rockenstein, Michael Mante, Anthony Adame, Shing Fai Chan, Traci Fang Newmeyer, Eliezer Masliah, Nobuki Nakanishi, Stuart A Lipton

Published in: Molecular Neurodegeneration | Issue 1/2013

Login to get access

Abstract

Background

Mutations in the gene encoding parkin, a neuroprotective protein with dual functions as an E3 ubiquitin ligase and transcriptional repressor of p53, are linked to familial forms of Parkinson’s disease (PD). We hypothesized that oxidative posttranslational modification of parkin by environmental toxins may contribute to sporadic PD.

Results

We first demonstrated that S-nitrosylation of parkin decreased its activity as a repressor of p53 gene expression, leading to upregulation of p53. Chromatin immunoprecipitation as well as gel-shift assays showed that parkin bound to the p53 promoter, and this binding was inhibited by S-nitrosylation of parkin. Additionally, nitrosative stress induced apoptosis in cells expressing parkin, and this death was, at least in part, dependent upon p53. In primary mesencephalic cultures, pesticide-induced apoptosis was prevented by inhibition of nitric oxide synthase (NOS). In a mouse model of pesticide-induced PD, both S-nitrosylated (SNO-)parkin and p53 protein levels were increased, while administration of a NOS inhibitor mitigated neuronal death in these mice. Moreover, the levels of SNO-parkin and p53 were simultaneously elevated in postmortem human PD brain compared to controls.

Conclusions

Taken together, our data indicate that S-nitrosylation of parkin, leading to p53-mediated neuronal cell death, contributes to the pathophysiology of sporadic PD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B, et al: The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol. 1995, 142: 820-827.PubMed Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B, et al: The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol. 1995, 142: 820-827.PubMed
2.
go back to reference Giasson BI, Lee VM: Are ubiquitination pathways central to Parkinson’s disease?. Cell. 2003, 114: 1-8. 10.1016/S0092-8674(03)00509-9.CrossRefPubMed Giasson BI, Lee VM: Are ubiquitination pathways central to Parkinson’s disease?. Cell. 2003, 114: 1-8. 10.1016/S0092-8674(03)00509-9.CrossRefPubMed
3.
go back to reference Jenner P: Oxidative stress in Parkinson’s disease. Ann Neurol. 2003, 3 (53): S26-36. discussion S36-28CrossRef Jenner P: Oxidative stress in Parkinson’s disease. Ann Neurol. 2003, 3 (53): S26-36. discussion S36-28CrossRef
4.
go back to reference Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834.CrossRefPubMed Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834.CrossRefPubMed
5.
go back to reference Langston JW: Parkinson’s disease: current and future challenges. Neurotoxicology. 2002, 23: 443-450. 10.1016/S0161-813X(02)00098-0.CrossRefPubMed Langston JW: Parkinson’s disease: current and future challenges. Neurotoxicology. 2002, 23: 443-450. 10.1016/S0161-813X(02)00098-0.CrossRefPubMed
6.
go back to reference Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.CrossRefPubMed Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.CrossRefPubMed
7.
go back to reference Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, et al: Association between early-onset Parkinson’s disease and mutations in the parkin gene. The New England journal of medicine. 2000, 342: 1560-1567. 10.1056/NEJM200005253422103.CrossRefPubMed Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, et al: Association between early-onset Parkinson’s disease and mutations in the parkin gene. The New England journal of medicine. 2000, 342: 1560-1567. 10.1056/NEJM200005253422103.CrossRefPubMed
8.
go back to reference Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, et al: Parkin mutations and susceptibility alleles in late-onset Parkinson’s disease. Ann Neurol. 2003, 53: 624-629. 10.1002/ana.10524.CrossRefPubMed Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, et al: Parkin mutations and susceptibility alleles in late-onset Parkinson’s disease. Ann Neurol. 2003, 53: 624-629. 10.1002/ana.10524.CrossRefPubMed
9.
go back to reference Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.CrossRefPubMed Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.CrossRefPubMed
10.
go back to reference Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000, 97: 13354-13359. 10.1073/pnas.240347797.PubMedCentralCrossRefPubMed Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000, 97: 13354-13359. 10.1073/pnas.240347797.PubMedCentralCrossRefPubMed
11.
go back to reference Bence NF, Sampat RM, Kopito RR: Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001, 292: 1552-1555. 10.1126/science.292.5521.1552.CrossRefPubMed Bence NF, Sampat RM, Kopito RR: Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001, 292: 1552-1555. 10.1126/science.292.5521.1552.CrossRefPubMed
12.
go back to reference Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson’s disease. Science. 2003, 302: 819-822. 10.1126/science.1087753.CrossRefPubMed Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson’s disease. Science. 2003, 302: 819-822. 10.1126/science.1087753.CrossRefPubMed
13.
go back to reference Feany MB, Pallanck LJ: Parkin: a multipurpose neuroprotective agent?. Neuron. 2003, 38: 13-16. 10.1016/S0896-6273(03)00201-0.CrossRefPubMed Feany MB, Pallanck LJ: Parkin: a multipurpose neuroprotective agent?. Neuron. 2003, 38: 13-16. 10.1016/S0896-6273(03)00201-0.CrossRefPubMed
14.
go back to reference Jiang H, Ren Y, Zhao J, Feng J: Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004, 13: 1745-1754. 10.1093/hmg/ddh180.CrossRefPubMed Jiang H, Ren Y, Zhao J, Feng J: Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004, 13: 1745-1754. 10.1093/hmg/ddh180.CrossRefPubMed
15.
go back to reference Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000, 287: 1265-1269. 10.1126/science.287.5456.1265.CrossRefPubMed Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000, 287: 1265-1269. 10.1126/science.287.5456.1265.CrossRefPubMed
16.
go back to reference von Coelln R, Dawson VL, Dawson TM: Parkin-associated Parkinson’s disease. Cell Tissue Res. 2004, 318: 175-184. 10.1007/s00441-004-0924-4.CrossRefPubMed von Coelln R, Dawson VL, Dawson TM: Parkin-associated Parkinson’s disease. Cell Tissue Res. 2004, 318: 175-184. 10.1007/s00441-004-0924-4.CrossRefPubMed
17.
go back to reference Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, et al: Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2007, 27: 1868-1878. 10.1523/JNEUROSCI.5537-06.2007.CrossRef Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, et al: Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2007, 27: 1868-1878. 10.1523/JNEUROSCI.5537-06.2007.CrossRef
18.
go back to reference Johnson BN, Berger AK, Cortese GP, Lavoie MJ: The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc Natl Acad Sci U S A. 2012, 109: 6283-6288. 10.1073/pnas.1113248109.PubMedCentralCrossRefPubMed Johnson BN, Berger AK, Cortese GP, Lavoie MJ: The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc Natl Acad Sci U S A. 2012, 109: 6283-6288. 10.1073/pnas.1113248109.PubMedCentralCrossRefPubMed
19.
go back to reference Alves Da Costa C, Checler F: Apoptosis in Parkinson’s disease: is p53 the missing link between genetic and sporadic Parkinsonism?. Cell Signal. 2011, 23: 963-968. 10.1016/j.cellsig.2010.10.020.CrossRefPubMed Alves Da Costa C, Checler F: Apoptosis in Parkinson’s disease: is p53 the missing link between genetic and sporadic Parkinsonism?. Cell Signal. 2011, 23: 963-968. 10.1016/j.cellsig.2010.10.020.CrossRefPubMed
20.
go back to reference da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, et al: Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson’s disease. Nat Cell Biol. 2009, 11: 1370-1375. 10.1038/ncb1981.PubMedCentralCrossRefPubMed da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, et al: Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson’s disease. Nat Cell Biol. 2009, 11: 1370-1375. 10.1038/ncb1981.PubMedCentralCrossRefPubMed
21.
go back to reference Gu Z, Nakamura T, Yao D, Shi ZQ, Lipton SA: Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson’s disease. Cell Death Differ. 2005, 12: 1202-1204. 10.1038/sj.cdd.4401705.CrossRefPubMed Gu Z, Nakamura T, Yao D, Shi ZQ, Lipton SA: Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson’s disease. Cell Death Differ. 2005, 12: 1202-1204. 10.1038/sj.cdd.4401705.CrossRefPubMed
22.
go back to reference Vance JM, Ali S, Bradley WG, Singer C, Di Monte DA: Gene-environment interactions in Parkinson’s disease and other forms of parkinsonism. Neurotoxicology. 2010, 31: 598-602. 10.1016/j.neuro.2010.04.007.CrossRefPubMed Vance JM, Ali S, Bradley WG, Singer C, Di Monte DA: Gene-environment interactions in Parkinson’s disease and other forms of parkinsonism. Neurotoxicology. 2010, 31: 598-602. 10.1016/j.neuro.2010.04.007.CrossRefPubMed
23.
go back to reference Wang C, Ko HS, Thomas B, Tsang F, Chew KC, Tay SP, Ho MW, Lim TM, Soong TW, Pletnikova O, et al: Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin’s protective function. Hum Mol Genet. 2005, 14: 3885-3897. 10.1093/hmg/ddi413.CrossRefPubMed Wang C, Ko HS, Thomas B, Tsang F, Chew KC, Tay SP, Ho MW, Lim TM, Soong TW, Pletnikova O, et al: Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin’s protective function. Hum Mol Genet. 2005, 14: 3885-3897. 10.1093/hmg/ddi413.CrossRefPubMed
24.
go back to reference Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM: S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science. 2004, 304: 1328-1331. 10.1126/science.1093891.CrossRefPubMed Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM: S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science. 2004, 304: 1328-1331. 10.1126/science.1093891.CrossRefPubMed
25.
go back to reference Meng F, Yao D, Shi Y, Kabakoff J, Wu W, Reicher J, Ma Y, Moosmann B, Masliah E, Lipton SA, Gu Z: Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener. 2011, 6: 34-10.1186/1750-1326-6-34.PubMedCentralCrossRefPubMed Meng F, Yao D, Shi Y, Kabakoff J, Wu W, Reicher J, Ma Y, Moosmann B, Masliah E, Lipton SA, Gu Z: Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener. 2011, 6: 34-10.1186/1750-1326-6-34.PubMedCentralCrossRefPubMed
26.
go back to reference Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, et al: Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A. 2004, 101: 10810-10814. 10.1073/pnas.0404161101.PubMedCentralCrossRefPubMed Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, et al: Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A. 2004, 101: 10810-10814. 10.1073/pnas.0404161101.PubMedCentralCrossRefPubMed
27.
go back to reference Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B: Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009, 169: 919-926. 10.1093/aje/kwp006.PubMedCentralCrossRefPubMed Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B: Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009, 169: 919-926. 10.1093/aje/kwp006.PubMedCentralCrossRefPubMed
28.
go back to reference Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC: Environmental risk factors and Parkinson’s disease: a case–control study in Taiwan. Neurology. 1997, 48: 1583-1588. 10.1212/WNL.48.6.1583.CrossRefPubMed Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC: Environmental risk factors and Parkinson’s disease: a case–control study in Taiwan. Neurology. 1997, 48: 1583-1588. 10.1212/WNL.48.6.1583.CrossRefPubMed
29.
go back to reference Meco G, Bonifati V, Vanacore N, Fabrizio E: Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scandinavian journal of work, environment & health. 1994, 20: 301-305. 10.5271/sjweh.1394.CrossRef Meco G, Bonifati V, Vanacore N, Fabrizio E: Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scandinavian journal of work, environment & health. 1994, 20: 301-305. 10.5271/sjweh.1394.CrossRef
30.
go back to reference Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE: Systemic exposure to paraquat and maneb models early Parkinson’s disease in young adult rats. Neurobiol Dis. 2005, 20: 360-371. 10.1016/j.nbd.2005.03.018.CrossRefPubMed Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE: Systemic exposure to paraquat and maneb models early Parkinson’s disease in young adult rats. Neurobiol Dis. 2005, 20: 360-371. 10.1016/j.nbd.2005.03.018.CrossRefPubMed
31.
go back to reference Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA: Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?. Brain research. 2000, 873: 225-234. 10.1016/S0006-8993(00)02496-3.CrossRefPubMed Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA: Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?. Brain research. 2000, 873: 225-234. 10.1016/S0006-8993(00)02496-3.CrossRefPubMed
32.
go back to reference Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA: The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson’s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2000, 20: 9207-9214. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA: The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson’s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2000, 20: 9207-9214.
33.
go back to reference Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA: Developmental exposure to the pesticides paraquat and maneb and the Parkinson’s disease phenotype. Neurotoxicology. 2002, 23: 621-633. 10.1016/S0161-813X(02)00092-X.CrossRefPubMed Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA: Developmental exposure to the pesticides paraquat and maneb and the Parkinson’s disease phenotype. Neurotoxicology. 2002, 23: 621-633. 10.1016/S0161-813X(02)00092-X.CrossRefPubMed
34.
go back to reference Zeevalk GD, Bernard LP, Guilford FT: Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochem Res. 2010, 35: 1575-1587. 10.1007/s11064-010-0217-0.CrossRefPubMed Zeevalk GD, Bernard LP, Guilford FT: Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochem Res. 2010, 35: 1575-1587. 10.1007/s11064-010-0217-0.CrossRefPubMed
35.
go back to reference Desplats P, Patel P, Kosberg K, Mante M, Patrick C, Rockenstein E, Fujita M, Hashimoto M, Masliah E: Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease. Mol Neurodegener. 2012, 7: 49-10.1186/1750-1326-7-49.PubMedCentralCrossRefPubMed Desplats P, Patel P, Kosberg K, Mante M, Patrick C, Rockenstein E, Fujita M, Hashimoto M, Masliah E: Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease. Mol Neurodegener. 2012, 7: 49-10.1186/1750-1326-7-49.PubMedCentralCrossRefPubMed
36.
go back to reference Hoglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC: Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004, 7: 726-735. 10.1038/nn1265.CrossRefPubMed Hoglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC: Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004, 7: 726-735. 10.1038/nn1265.CrossRefPubMed
37.
go back to reference Marxreiter F, Regensburger M, Winkler J: Adult neurogenesis in Parkinson’s disease. Cellular and molecular life sciences: CMLS. 2013, 70: 459-473. 10.1007/s00018-012-1062-x.CrossRefPubMed Marxreiter F, Regensburger M, Winkler J: Adult neurogenesis in Parkinson’s disease. Cellular and molecular life sciences: CMLS. 2013, 70: 459-473. 10.1007/s00018-012-1062-x.CrossRefPubMed
38.
go back to reference Duplan E, Sevalle J, Viotti J, Goiran T, Bauer C, Renbaum P, Levy-Lahad E, Gautier CA, Corti O, Leroudier N, et al: Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription. Journal of molecular cell biology. 2013, 5: 132-142. 10.1093/jmcb/mjt003.CrossRefPubMed Duplan E, Sevalle J, Viotti J, Goiran T, Bauer C, Renbaum P, Levy-Lahad E, Gautier CA, Corti O, Leroudier N, et al: Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription. Journal of molecular cell biology. 2013, 5: 132-142. 10.1093/jmcb/mjt003.CrossRefPubMed
39.
go back to reference Zhang C, Lin M, Wu R, Wang X, Yang B, Levine AJ, Hu W, Feng Z: Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A. 2011, 108: 16259-16264. 10.1073/pnas.1113884108.PubMedCentralCrossRefPubMed Zhang C, Lin M, Wu R, Wang X, Yang B, Levine AJ, Hu W, Feng Z: Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A. 2011, 108: 16259-16264. 10.1073/pnas.1113884108.PubMedCentralCrossRefPubMed
40.
go back to reference Viotti J, Duplan E, Caillava C, Condat J, Goiran T, Giordano C, Marie Y, Idbaih A, Delattre JY, Honnorat J, et al: Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity. Oncogene. 2013, 10.1038/onc.2013.124. Viotti J, Duplan E, Caillava C, Condat J, Goiran T, Giordano C, Marie Y, Idbaih A, Delattre JY, Honnorat J, et al: Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity. Oncogene. 2013, 10.1038/onc.2013.124.
41.
go back to reference Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, Li S: Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson’s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011, 31: 157-163. 10.1523/JNEUROSCI.1833-10.2011.CrossRef Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, Li S: Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson’s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011, 31: 157-163. 10.1523/JNEUROSCI.1833-10.2011.CrossRef
42.
go back to reference Duncan AJ, Heales SJ: Nitric oxide and neurological disorders. Mol Aspects Med. 2005, 26: 67-96. 10.1016/j.mam.2004.09.004.CrossRefPubMed Duncan AJ, Heales SJ: Nitric oxide and neurological disorders. Mol Aspects Med. 2005, 26: 67-96. 10.1016/j.mam.2004.09.004.CrossRefPubMed
43.
go back to reference Li X, Ye X, Li X, Sun X, Liang Q, Tao L, Kang X, Chen J: Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res. 2011, 1382: 9-18.CrossRefPubMed Li X, Ye X, Li X, Sun X, Liang Q, Tao L, Kang X, Chen J: Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res. 2011, 1382: 9-18.CrossRefPubMed
44.
go back to reference Singh S, Dikshit M: Apoptotic neuronal death in Parkinson’s disease: involvement of nitric oxide. Brain Res Rev. 2007, 54: 233-250. 10.1016/j.brainresrev.2007.02.001.CrossRefPubMed Singh S, Dikshit M: Apoptotic neuronal death in Parkinson’s disease: involvement of nitric oxide. Brain Res Rev. 2007, 54: 233-250. 10.1016/j.brainresrev.2007.02.001.CrossRefPubMed
45.
go back to reference Zhang L, Dawson VL, Dawson TM: Role of nitric oxide in Parkinson’s disease. Pharmacol Therapeut. 2006, 109: 33-41. 10.1016/j.pharmthera.2005.05.007.CrossRef Zhang L, Dawson VL, Dawson TM: Role of nitric oxide in Parkinson’s disease. Pharmacol Therapeut. 2006, 109: 33-41. 10.1016/j.pharmthera.2005.05.007.CrossRef
46.
go back to reference Barthwal MK, Srivastava N, Shukla R, Nag D, Seth PK, Srimal RC, Dikshit M: Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson’s disease patients. Acta neurologica Scandinavica. 1999, 100: 300-304.CrossRefPubMed Barthwal MK, Srivastava N, Shukla R, Nag D, Seth PK, Srimal RC, Dikshit M: Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson’s disease patients. Acta neurologica Scandinavica. 1999, 100: 300-304.CrossRefPubMed
47.
go back to reference Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz ML, Poderoso JJ: Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson’s disease. Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society. 2000, 4: 534-539. 10.1006/niox.2000.0288.CrossRef Gatto EM, Riobo NA, Carreras MC, Chernavsky A, Rubio A, Satz ML, Poderoso JJ: Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson’s disease. Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society. 2000, 4: 534-539. 10.1006/niox.2000.0288.CrossRef
48.
go back to reference Singh S, Das T, Ravindran A, Chaturvedi RK, Shukla Y, Agarwal AK, Dikshit M: Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson’s disease. Redox report : communications in free radical research. 2005, 10: 103-109. 10.1179/135100005X38842.CrossRefPubMed Singh S, Das T, Ravindran A, Chaturvedi RK, Shukla Y, Agarwal AK, Dikshit M: Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson’s disease. Redox report : communications in free radical research. 2005, 10: 103-109. 10.1179/135100005X38842.CrossRefPubMed
49.
go back to reference Jenner P, Olanow CW: Understanding cell death in Parkinson’s disease. Ann Neurol. 1998, 44: S72-84.CrossRefPubMed Jenner P, Olanow CW: Understanding cell death in Parkinson’s disease. Ann Neurol. 1998, 44: S72-84.CrossRefPubMed
50.
go back to reference Packer MA, Stasiv Y, Benraiss A, Chmielnicki E, Grinberg A, Westphal H, Goldman SA, Enikolopov G: Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A. 2003, 100: 9566-9571. 10.1073/pnas.1633579100.PubMedCentralCrossRefPubMed Packer MA, Stasiv Y, Benraiss A, Chmielnicki E, Grinberg A, Westphal H, Goldman SA, Enikolopov G: Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A. 2003, 100: 9566-9571. 10.1073/pnas.1633579100.PubMedCentralCrossRefPubMed
51.
go back to reference Zhu XJ, Hua Y, Jiang J, Zhou QG, Luo CX, Han X, Lu YM, Zhu DY: Neuronal nitric oxide synthase-derived nitric oxide inhibits neurogenesis in the adult dentate gyrus by down-regulating cyclic AMP response element binding protein phosphorylation. Neuroscience. 2006, 141: 827-836. 10.1016/j.neuroscience.2006.04.032.CrossRefPubMed Zhu XJ, Hua Y, Jiang J, Zhou QG, Luo CX, Han X, Lu YM, Zhu DY: Neuronal nitric oxide synthase-derived nitric oxide inhibits neurogenesis in the adult dentate gyrus by down-regulating cyclic AMP response element binding protein phosphorylation. Neuroscience. 2006, 141: 827-836. 10.1016/j.neuroscience.2006.04.032.CrossRefPubMed
52.
go back to reference Brune B, von Knethen A, Sandau KB: Transcription factors p53 and HIF-1alpha as targets of nitric oxide. Cell Signal. 2001, 13: 525-533. 10.1016/S0898-6568(01)00175-9.CrossRefPubMed Brune B, von Knethen A, Sandau KB: Transcription factors p53 and HIF-1alpha as targets of nitric oxide. Cell Signal. 2001, 13: 525-533. 10.1016/S0898-6568(01)00175-9.CrossRefPubMed
53.
go back to reference Calmels S, Hainaut P, Ohshima H: Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer research. 1997, 57: 3365-3369.PubMed Calmels S, Hainaut P, Ohshima H: Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer research. 1997, 57: 3365-3369.PubMed
54.
go back to reference Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Bio. 2005, 6: 150-166. 10.1038/nrm1569.CrossRef Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Bio. 2005, 6: 150-166. 10.1038/nrm1569.CrossRef
55.
go back to reference Schonhoff CM, Daou MC, Jones SN, Schiffer CA, Ross AH: Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry. 2002, 41: 13570-13574. 10.1021/bi026262q.CrossRefPubMed Schonhoff CM, Daou MC, Jones SN, Schiffer CA, Ross AH: Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry. 2002, 41: 13570-13574. 10.1021/bi026262q.CrossRefPubMed
56.
go back to reference Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B: Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action. Exp Cell Res. 2011, 317: 1359-1367. 10.1016/j.yexcr.2011.03.001.PubMedCentralCrossRefPubMed Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B: Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action. Exp Cell Res. 2011, 317: 1359-1367. 10.1016/j.yexcr.2011.03.001.PubMedCentralCrossRefPubMed
57.
go back to reference Blum D, Wu Y, Nissou MF, Arnaud S, Alim Louis B, Verna JM: p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain research. 1997, 751: 139-142. 10.1016/S0006-8993(96)01358-3.CrossRefPubMed Blum D, Wu Y, Nissou MF, Arnaud S, Alim Louis B, Verna JM: p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain research. 1997, 751: 139-142. 10.1016/S0006-8993(96)01358-3.CrossRefPubMed
58.
go back to reference Mandir AS, Simbulan-Rosenthal CM, Poitras MF, Lumpkin JR, Dawson VL, Smulson ME, Dawson TM: A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. Journal of neurochemistry. 2002, 83: 186-192. 10.1046/j.1471-4159.2002.01144.x.CrossRefPubMed Mandir AS, Simbulan-Rosenthal CM, Poitras MF, Lumpkin JR, Dawson VL, Smulson ME, Dawson TM: A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. Journal of neurochemistry. 2002, 83: 186-192. 10.1046/j.1471-4159.2002.01144.x.CrossRefPubMed
59.
go back to reference Nair VD: Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease. Apoptosis : an international journal on programmed cell death. 2006, 11: 955-966. 10.1007/s10495-006-6316-3.CrossRef Nair VD: Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease. Apoptosis : an international journal on programmed cell death. 2006, 11: 955-966. 10.1007/s10495-006-6316-3.CrossRef
60.
go back to reference Morrison RS, Kinoshita Y: The role of p53 in neuronal cell death. Cell death and differentiation. 2000, 7: 868-879. 10.1038/sj.cdd.4400741.CrossRefPubMed Morrison RS, Kinoshita Y: The role of p53 in neuronal cell death. Cell death and differentiation. 2000, 7: 868-879. 10.1038/sj.cdd.4400741.CrossRefPubMed
61.
go back to reference Duan W, Zhu X, Ladenheim B, Yu QS, Guo Z, Oyler J, Cutler RG, Cadet JL, Greig NH, Mattson MP: p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Annals of neurology. 2002, 52: 597-606. 10.1002/ana.10350.CrossRefPubMed Duan W, Zhu X, Ladenheim B, Yu QS, Guo Z, Oyler J, Cutler RG, Cadet JL, Greig NH, Mattson MP: p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Annals of neurology. 2002, 52: 597-606. 10.1002/ana.10350.CrossRefPubMed
62.
go back to reference Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994, 367: 188-193. 10.1038/367188a0.CrossRefPubMed Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994, 367: 188-193. 10.1038/367188a0.CrossRefPubMed
63.
go back to reference Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia-Bonnefil P: Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006, 26: 1107-1116. 10.1523/JNEUROSCI.3970-05.2006.CrossRef Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia-Bonnefil P: Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006, 26: 1107-1116. 10.1523/JNEUROSCI.3970-05.2006.CrossRef
64.
go back to reference De la Monte SM, Sohn YK, Ganju N, Wands JR: P53- and CD95-associated apoptosis in neurodegenerative diseases. Laboratory investigation; a journal of technical methods and pathology. 1998, 78: 401-411.PubMed De la Monte SM, Sohn YK, Ganju N, Wands JR: P53- and CD95-associated apoptosis in neurodegenerative diseases. Laboratory investigation; a journal of technical methods and pathology. 1998, 78: 401-411.PubMed
65.
go back to reference Mogi M, Kondo T, Mizuno Y, Nagatsu T: p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neuroscience letters. 2007, 414: 94-97. 10.1016/j.neulet.2006.12.003.CrossRefPubMed Mogi M, Kondo T, Mizuno Y, Nagatsu T: p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neuroscience letters. 2007, 414: 94-97. 10.1016/j.neulet.2006.12.003.CrossRefPubMed
66.
go back to reference Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM: Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. The American journal of pathology. 2007, 170: 658-666. 10.2353/ajpath.2007.060359.PubMedCentralCrossRefPubMed Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM: Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. The American journal of pathology. 2007, 170: 658-666. 10.2353/ajpath.2007.060359.PubMedCentralCrossRefPubMed
67.
go back to reference Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, Mallory M, Alford M, Masliah E: Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. The Journal of experimental medicine. 1995, 181: 1551-1556. 10.1084/jem.181.4.1551.CrossRefPubMed Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, Mallory M, Alford M, Masliah E: Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. The Journal of experimental medicine. 1995, 181: 1551-1556. 10.1084/jem.181.4.1551.CrossRefPubMed
68.
go back to reference Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH: Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nature cell biology. 2001, 3: 193-197. 10.1038/35055104.CrossRefPubMed Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH: Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nature cell biology. 2001, 3: 193-197. 10.1038/35055104.CrossRefPubMed
69.
go back to reference Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006, 441: 513-517. 10.1038/nature04782.CrossRefPubMed Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006, 441: 513-517. 10.1038/nature04782.CrossRefPubMed
70.
go back to reference Eckardt-Michel J, Lorek M, Baxmann D, Grunwald T, Keil GM, Zimmer G: The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. Journal of virology. 2008, 82: 3236-3249. 10.1128/JVI.01887-07.PubMedCentralCrossRefPubMed Eckardt-Michel J, Lorek M, Baxmann D, Grunwald T, Keil GM, Zimmer G: The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. Journal of virology. 2008, 82: 3236-3249. 10.1128/JVI.01887-07.PubMedCentralCrossRefPubMed
71.
go back to reference Louis M, Zanou N, Van Schoor M, Gailly P: TRPC1 regulates skeletal myoblast migration and differentiation. Journal of cell science. 2008, 121: 3951-3959. 10.1242/jcs.037218.CrossRefPubMed Louis M, Zanou N, Van Schoor M, Gailly P: TRPC1 regulates skeletal myoblast migration and differentiation. Journal of cell science. 2008, 121: 3951-3959. 10.1242/jcs.037218.CrossRefPubMed
Metadata
Title
S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease
Authors
Carmen R Sunico
Tomohiro Nakamura
Edward Rockenstein
Michael Mante
Anthony Adame
Shing Fai Chan
Traci Fang Newmeyer
Eliezer Masliah
Nobuki Nakanishi
Stuart A Lipton
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2013
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-8-29

Other articles of this Issue 1/2013

Molecular Neurodegeneration 1/2013 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgement